10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001213900-23-066850 |
| Period End Date | 20230630 |
| Filing Date | 20230814 |
| Fiscal Year | 2023 |
| Fiscal Period | Q2 |
| XBRL Instance | f10q0623_ponygroup_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Ordinary shares, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Ordinary shares, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Ordinary shares, authorized |
CommonStockSharesAuthorized
|
70.00M | shares | Point-in-time |
| Ordinary shares, authorized |
CommonStockSharesAuthorized
|
70.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$49.80K | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$31.68K | USD | Point-in-time |
| Ordinary shares, issued |
CommonStockSharesIssued
|
11.50M | shares | Point-in-time |
| Ordinary shares, issued |
CommonStockSharesIssued
|
11.50M | shares | Point-in-time |
| Ordinary shares, outstanding |
CommonStockSharesOutstanding
|
11.50M | shares | Point-in-time |
| Ordinary shares, outstanding |
CommonStockSharesOutstanding
|
11.50M | shares | Point-in-time |
| Accounts receivables |
AccountsReceivableNetCurrent
|
$10.72K | USD | Point-in-time |
| Accounts receivables |
AccountsReceivableNetCurrent
|
$8.72K | USD | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$16.82K | USD | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$285.00 | USD | Point-in-time |
| Other receivables-related parties |
AccountsAndOtherReceivablesNetCurrent
|
$9.00K | USD | Point-in-time |
| Other receivables-related parties |
AccountsAndOtherReceivablesNetCurrent
|
$9.00K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$66.22K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$69.81K | USD | Point-in-time |
| Total assets |
Assets
|
$69.81K | USD | Point-in-time |
| Total assets |
Assets
|
$66.22K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$31.34K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$31.78K | USD | Point-in-time |
| Other payable- related parties |
NotesPayableCurrent
|
$378.75K | USD | Point-in-time |
| Other payable- related parties |
NotesPayableCurrent
|
$431.84K | USD | Point-in-time |
| Other current liability |
OtherLiabilitiesCurrent
|
$45.41K | USD | Point-in-time |
| Other current liability |
OtherLiabilitiesCurrent
|
$15.26K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$425.35K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$509.03K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$509.03K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$425.35K | USD | Point-in-time |
| Ordinary shares, $0.001 par value, 70,000,000 shares authorized, 11,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 |
CommonStockValue
|
$11.50K | USD | Point-in-time |
| Ordinary shares, $0.001 par value, 70,000,000 shares authorized, 11,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 |
CommonStockValue
|
$11.50K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$176.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$176.00K | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
$6.36K | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
$21.50K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-651.81K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-549.40K | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-442.81K | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-355.54K | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$69.81K | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$66.22K | USD | Point-in-time |
Income Statement
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.01 | USD | 1 Quarter |
| Revenue |
Revenues
|
$47.23K | USD | 1 Quarter |
| Revenue |
Revenues
|
$23.70K | USD | 1 Quarter |
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.01 | USD | 2 Qtrs |
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.02 | USD | 2 Qtrs |
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.00 | USD | 1 Quarter |
| Revenue |
Revenues
|
$53.56K | USD | 2 Qtrs |
| Revenue |
Revenues
|
$103.39K | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$45.47K | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$20.87K | USD | 1 Quarter |
| Cost of revenue |
CostOfRevenue
|
$31.59K | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$6.77K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$26.36K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$16.93K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$21.97K | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$57.92K | USD | 2 Qtrs |
| General & administrative expenses |
GeneralAndAdministrativeExpense
|
$160.41K | USD | 2 Qtrs |
| General & administrative expenses |
GeneralAndAdministrativeExpense
|
$71.87K | USD | 1 Quarter |
| General & administrative expenses |
GeneralAndAdministrativeExpense
|
$238.12K | USD | 2 Qtrs |
| General & administrative expenses |
GeneralAndAdministrativeExpense
|
$123.78K | USD | 1 Quarter |
| R&D expense |
ResearchAndDevelopmentExpense
|
- | USD | 2 Qtrs |
| R&D expense |
ResearchAndDevelopmentExpense
|
$17.26K | USD | 2 Qtrs |
| R&D expense |
ResearchAndDevelopmentExpense
|
- | USD | 1 Quarter |
| R&D expense |
ResearchAndDevelopmentExpense
|
$10.19K | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$133.96K | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$71.87K | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$255.38K | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$160.41K | USD | 2 Qtrs |
| Loss from operation |
OperatingIncomeLoss
|
$-45.51K | USD | 1 Quarter |
| Loss from operation |
OperatingIncomeLoss
|
$-102.49K | USD | 2 Qtrs |
| Loss from operation |
OperatingIncomeLoss
|
$-117.03K | USD | 1 Quarter |
| Loss from operation |
OperatingIncomeLoss
|
$-233.41K | USD | 2 Qtrs |
| Other income (expense) |
OtherNonoperatingIncomeExpense
|
$439.00 | USD | 2 Qtrs |
| Other income (expense) |
OtherNonoperatingIncomeExpense
|
$-77.00 | USD | 2 Qtrs |
| Other income (expense) |
OtherNonoperatingIncomeExpense
|
$-156.00 | USD | 1 Quarter |
| Other income (expense) |
OtherNonoperatingIncomeExpense
|
$473.00 | USD | 1 Quarter |
| Total other income (expense) |
OtherIncome
|
$439.00 | USD | 2 Qtrs |
| Total other income (expense) |
OtherIncome
|
$-156.00 | USD | 1 Quarter |
| Total other income (expense) |
OtherIncome
|
$473.00 | USD | 1 Quarter |
| Total other income (expense) |
OtherIncome
|
$-77.00 | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
$-45.36K | USD | 1 Quarter |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
$-233.85K | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
$-117.51K | USD | 1 Quarter |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
$-102.41K | USD | 2 Qtrs |
| Provision for income tax |
IncomeTaxExpenseBenefit
|
- | USD | 1 Quarter |
| Provision for income tax |
IncomeTaxExpenseBenefit
|
- | USD | 2 Qtrs |
| Provision for income tax |
IncomeTaxExpenseBenefit
|
- | USD | 2 Qtrs |
| Provision for income tax |
IncomeTaxExpenseBenefit
|
- | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-45.36K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-102.41K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-116.34K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-117.51K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-233.85K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-57.05K | USD | 1 Quarter |
| Other Comprehensive Income |
OtherComprehensiveIncomeLossNetOfTax
|
$9.70K | USD | 1 Quarter |
| Other Comprehensive Income |
OtherComprehensiveIncomeLossNetOfTax
|
$9.26K | USD | 2 Qtrs |
| Other Comprehensive Income |
OtherComprehensiveIncomeLossNetOfTax
|
$15.14K | USD | 2 Qtrs |
| Other Comprehensive Income |
OtherComprehensiveIncomeLossNetOfTax
|
$16.04K | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-87.27K | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-107.81K | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-224.59K | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-29.32K | USD | 1 Quarter |
| Basic loss per common share (in Dollars per share) |
EarningsPerShareBasic
|
$-0.01 | USD | 1 Quarter |
| Basic loss per common share (in Dollars per share) |
EarningsPerShareBasic
|
$-0.02 | USD | 2 Qtrs |
| Basic loss per common share (in Dollars per share) |
EarningsPerShareBasic
|
$-0.01 | USD | 2 Qtrs |
| Basic loss per common share (in Dollars per share) |
EarningsPerShareBasic
|
$-0.00 | USD | 1 Quarter |
| Weighted average number of shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
11.50M | shares | 1 Quarter |
| Weighted average number of shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
11.50M | shares | 2 Qtrs |
| Weighted average number of shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
11.50M | shares | 1 Quarter |
| Weighted average number of shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
11.50M | shares | 2 Qtrs |
Cash Flow Statement
32 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net Loss |
NetIncomeLoss
|
$-45.36K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-102.41K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-116.34K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-117.51K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-233.85K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-57.05K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-2.00K | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-18.73K | USD | 2 Qtrs |
| Other receivable |
IncreaseDecreaseInOtherReceivables
|
$16.53K | USD | 2 Qtrs |
| Other receivable |
IncreaseDecreaseInOtherReceivables
|
$201.00 | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-5.76K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$436.00 | USD | 2 Qtrs |
| Other payable |
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
$30.16K | USD | 2 Qtrs |
| Other payable |
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
$-79.69K | USD | 2 Qtrs |
| Cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-86.35K | USD | 2 Qtrs |
| Cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-300.77K | USD | 2 Qtrs |
| Advance from related party |
ProceedsFromIssuanceOfCommonStock
|
$70.30K | USD | 2 Qtrs |
| Advance from related party |
ProceedsFromIssuanceOfCommonStock
|
$53.09K | USD | 2 Qtrs |
| Cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$53.09K | USD | 2 Qtrs |
| Cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$70.30K | USD | 2 Qtrs |
| Effects of currency translation on cash |
EffectsOfCurrencyTranslationOnCash
|
$-15.14K | USD | 2 Qtrs |
| Effects of currency translation on cash |
EffectsOfCurrencyTranslationOnCash
|
$-9.26K | USD | 2 Qtrs |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$-18.12K | USD | 2 Qtrs |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$-221.21K | USD | 2 Qtrs |
| Cash at beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.68K | USD | Point-in-time |
| Cash at beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$266.01K | USD | Point-in-time |
| Cash at beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$49.80K | USD | Point-in-time |
| Cash at beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$44.80K | USD | Point-in-time |
| Cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.68K | USD | Point-in-time |
| Cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$266.01K | USD | Point-in-time |
| Cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$49.80K | USD | Point-in-time |
| Cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$44.80K | USD | Point-in-time |
Stockholders Equity
22 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquity
|
$-327.57K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-413.50K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-355.54K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-219.77K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-102.98K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-442.81K | USD | Point-in-time |
| Cumulative Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$9.70K | USD | 1 Quarter |
| Cumulative Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$16.04K | USD | 1 Quarter |
| Cumulative Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-899.00 | USD | 1 Quarter |
| Cumulative Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-442.00 | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-45.36K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-102.41K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-116.34K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-117.51K | USD | 1 Quarter |
| Net Loss |
NetIncomeLoss
|
$-233.85K | USD | 2 Qtrs |
| Net Loss |
NetIncomeLoss
|
$-57.05K | USD | 1 Quarter |
| Balance |
StockholdersEquity
|
$-327.57K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-413.50K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-355.54K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-219.77K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-102.98K | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-442.81K | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.